HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-NOV-01 1IS0 TITLE CRYSTAL STRUCTURE OF A COMPLEX OF THE SRC SH2 DOMAIN WITH TITLE 2 CONFORMATIONALLY CONSTRAINED PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE TRANSFORMING PROTEIN SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SH2 DOMAIN; COMPND 5 SYNONYM: SRC; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: AY0 GLU GLU ILE PEPTIDE; COMPND 10 CHAIN: C, D; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ROUS SARCOMA VIRUS; SOURCE 3 ORGANISM_TAXID: 11886; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS CONFORMATIONALY CONSTRAINED INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.P.DAVIDSON,O.LUBMAN,T.ROSE,G.WAKSMAN,S.F.MARTIN REVDAT 7 16-OCT-24 1IS0 1 REMARK REVDAT 6 27-DEC-23 1IS0 1 LINK REVDAT 5 04-OCT-17 1IS0 1 REMARK REVDAT 4 13-JUL-11 1IS0 1 VERSN REVDAT 3 24-FEB-09 1IS0 1 VERSN REVDAT 2 14-JAN-03 1IS0 1 REMARK REVDAT 1 06-FEB-02 1IS0 0 JRNL AUTH J.P.DAVIDSON,O.LUBMAN,T.ROSE,G.WAKSMAN,S.F.MARTIN JRNL TITL CALORIMETRIC AND STRUCTURAL STUDIES OF 1,2,3-TRISUBSTITUTED JRNL TITL 2 CYCLOPROPANES AS CONFORMATIONALLY CONSTRAINED PEPTIDE JRNL TITL 3 INHIBITORS OF SRC SH2 DOMAIN BINDING. JRNL REF J.AM.CHEM.SOC. V. 124 205 2002 JRNL REFN ISSN 0002-7863 JRNL PMID 11782172 JRNL DOI 10.1021/JA011746F REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 578161.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 17894 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1770 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2521 REMARK 3 BIN R VALUE (WORKING SET) : 0.3760 REMARK 3 BIN FREE R VALUE : 0.4110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 308 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1724 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.730 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.970 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.780 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.310 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.060 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 48.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP_PTYR_PTR3.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IS0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-NOV-01. REMARK 100 THE DEPOSITION ID IS D_1000005221. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 53% MPD, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.17750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.65250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.25050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.65250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.17750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.25050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE PEPTIDE INHIBITOR IS A CONFORMATIONALLY CONSTRAINED ANALOG OF A REMARK 400 PHOSPHOTYROSINE-CONTAINING TETRAPEPTIDE REMARK 400 REMARK 400 THE AC-PTYR-GLU-GLU-ILE, PYEEI IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-PTYR-GLU-GLU-ILE, PYEEI REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 144 REMARK 465 ALA A 145 REMARK 465 SER A 248 REMARK 465 LYS A 249 REMARK 465 GLN B 144 REMARK 465 ALA B 145 REMARK 465 SER B 248 REMARK 465 LYS B 249 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 LYS A 181 CG CD CE NZ REMARK 470 ARG A 217 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 146 CG CD OE1 OE2 REMARK 470 ARG B 217 CG CD NE CZ NH1 NH2 REMARK 470 ILE C 255 O REMARK 470 ILE D 355 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 240 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 152 35.23 -82.14 REMARK 500 ALA A 194 -56.16 -168.54 REMARK 500 LYS B 152 42.93 -90.89 REMARK 500 ASP B 235 47.00 39.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF AY0 GLU GLU ILE REMARK 800 PEPTIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF AY0 GLU GLU ILE REMARK 800 PEPTIDE DBREF 1IS0 A 144 249 UNP P00524 SRC_RSVSA 144 249 DBREF 1IS0 B 144 249 UNP P00524 SRC_RSVSA 144 249 DBREF 1IS0 C 252 255 PDB 1IS0 1IS0 252 255 DBREF 1IS0 D 352 355 PDB 1IS0 1IS0 352 355 SEQRES 1 A 106 GLN ALA GLU GLU TRP TYR PHE GLY LYS ILE THR ARG ARG SEQRES 2 A 106 GLU SER GLU ARG LEU LEU LEU ASN PRO GLU ASN PRO ARG SEQRES 3 A 106 GLY THR PHE LEU VAL ARG GLU SER GLU THR THR LYS GLY SEQRES 4 A 106 ALA TYR CYS LEU SER VAL SER ASP PHE ASP ASN ALA LYS SEQRES 5 A 106 GLY LEU ASN VAL LYS HIS TYR LYS ILE ARG LYS LEU ASP SEQRES 6 A 106 SER GLY GLY PHE TYR ILE THR SER ARG THR GLN PHE SER SEQRES 7 A 106 SER LEU GLN GLN LEU VAL ALA TYR TYR SER LYS HIS ALA SEQRES 8 A 106 ASP GLY LEU CYS HIS ARG LEU THR ASN VAL CYS PRO THR SEQRES 9 A 106 SER LYS SEQRES 1 B 106 GLN ALA GLU GLU TRP TYR PHE GLY LYS ILE THR ARG ARG SEQRES 2 B 106 GLU SER GLU ARG LEU LEU LEU ASN PRO GLU ASN PRO ARG SEQRES 3 B 106 GLY THR PHE LEU VAL ARG GLU SER GLU THR THR LYS GLY SEQRES 4 B 106 ALA TYR CYS LEU SER VAL SER ASP PHE ASP ASN ALA LYS SEQRES 5 B 106 GLY LEU ASN VAL LYS HIS TYR LYS ILE ARG LYS LEU ASP SEQRES 6 B 106 SER GLY GLY PHE TYR ILE THR SER ARG THR GLN PHE SER SEQRES 7 B 106 SER LEU GLN GLN LEU VAL ALA TYR TYR SER LYS HIS ALA SEQRES 8 B 106 ASP GLY LEU CYS HIS ARG LEU THR ASN VAL CYS PRO THR SEQRES 9 B 106 SER LYS SEQRES 1 C 4 AY0 GLU GLU ILE SEQRES 1 D 4 AY0 GLU GLU ILE HET AY0 C 252 20 HET AY0 D 352 20 HETNAM AY0 (1R,2R,3S)-2-(METHYLCARBAMOYL)-3-[4-(PHOSPHONOOXY) HETNAM 2 AY0 PHENYL]CYCLOPROPANECARBOXYLIC ACID FORMUL 3 AY0 2(C12 H14 N O7 P) FORMUL 5 HOH *144(H2 O) HELIX 1 1 THR A 154 LEU A 163 1 10 HELIX 2 2 SER A 222 HIS A 233 1 12 HELIX 3 3 THR B 154 LEU B 163 1 10 HELIX 4 4 SER B 222 HIS B 233 1 12 SHEET 1 A 6 GLN A 219 PHE A 220 0 SHEET 2 A 6 PHE A 212 TYR A 213 -1 N PHE A 212 O PHE A 220 SHEET 3 A 6 GLY A 196 LYS A 206 -1 N ARG A 205 O TYR A 213 SHEET 4 A 6 TYR A 184 ASP A 192 -1 N TYR A 184 O ILE A 204 SHEET 5 A 6 THR A 171 GLU A 176 -1 N THR A 171 O SER A 189 SHEET 6 A 6 ASN A 243 VAL A 244 1 O ASN A 243 N PHE A 172 SHEET 1 B 6 GLN B 219 PHE B 220 0 SHEET 2 B 6 PHE B 212 TYR B 213 -1 N PHE B 212 O PHE B 220 SHEET 3 B 6 GLY B 196 LYS B 206 -1 N ARG B 205 O TYR B 213 SHEET 4 B 6 TYR B 184 ASP B 192 -1 N TYR B 184 O ILE B 204 SHEET 5 B 6 THR B 171 GLU B 176 -1 N THR B 171 O SER B 189 SHEET 6 B 6 ASN B 243 VAL B 244 1 O ASN B 243 N PHE B 172 LINK C AY0 C 252 N GLU C 253 1555 1555 1.33 LINK C AY0 D 352 N GLU D 353 1555 1555 1.32 SITE 1 AC1 22 ARG A 155 ARG A 175 SER A 177 GLU A 178 SITE 2 AC1 22 THR A 179 CYS A 185 LYS A 200 HIS A 201 SITE 3 AC1 22 TYR A 202 LYS A 203 ILE A 214 THR A 215 SITE 4 AC1 22 TYR A 230 ASP A 235 GLY A 236 LEU A 237 SITE 5 AC1 22 HOH A1029 ARG B 205 HOH C1010 HOH C1035 SITE 6 AC1 22 AY0 D 352 GLU D 354 SITE 1 AC2 25 ARG A 155 ARG A 156 GLU A 178 THR A 179 SITE 2 AC2 25 LYS B 152 ARG B 155 ARG B 175 SER B 177 SITE 3 AC2 25 GLU B 178 THR B 179 CYS B 185 LYS B 200 SITE 4 AC2 25 HIS B 201 TYR B 202 LYS B 203 ARG B 205 SITE 5 AC2 25 THR B 215 HOH B1081 HOH B1124 AY0 C 252 SITE 6 AC2 25 HOH D1022 HOH D1031 HOH D1043 HOH D1056 SITE 7 AC2 25 HOH D1121 CRYST1 58.355 56.501 69.305 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017136 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017699 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014429 0.00000